Few studies focusing on cerebrospinal fluid (CSF) levels of phosphorylated α-synuclein as a diagnostic marker of PD have shown increased concentrations in patients with PD compared to controls and patients with atypical parkinsonism [8]. This evidence concerns the gene SNCA and Parkinson disease.